1. Host genetic influences on the anthelmintic efficacy of papaya-derived cysteine proteinases in mice.
- Author
-
Luoga W, Mansur F, Stepek G, Lowe A, Duce IR, Buttle DJ, and Behnke JM
- Subjects
- Animals, Anthelmintics metabolism, Carica enzymology, Cimetidine pharmacology, Cysteine Proteases metabolism, Female, Gastrointestinal Tract drug effects, Gastrointestinal Tract parasitology, Genotype, Host Specificity, Hydrogen-Ion Concentration, Latex metabolism, Male, Mice, Mice, Inbred Strains, Nematospiroides drug effects, Nematospiroides physiology, Plant Proteins metabolism, Rodent Diseases drug therapy, Rodent Diseases parasitology, Species Specificity, Strongylida Infections drug therapy, Strongylida Infections parasitology, Anthelmintics pharmacology, Carica chemistry, Cysteine Proteases pharmacology, Latex pharmacology, Plant Proteins pharmacology, Rodent Diseases genetics, Strongylida Infections genetics
- Abstract
Eight strains of mice, of contrasting genotypes, infected with Heligmosomoides bakeri were studied to determine whether the anthelmintic efficacy of papaya latex varied between inbred mouse strains and therefore whether there is an underlying genetic influence on the effectiveness of removing the intestinal nematode. Infected mice were treated with 330 nmol of crude papaya latex or with 240 nmol of papaya latex supernatant (PLS). Wide variation of response between different mouse strains was detected. Treatment was most effective in C3H (90·5-99·3% reduction in worm counts) and least effective in CD1 and BALB/c strains (36·0 and 40·5%, respectively). Cimetidine treatment did not improve anthelmintic efficacy of PLS in a poor drug responder mouse strain. Trypsin activity, pH and PLS activity did not differ significantly along the length of the gastro-intestinal (GI) tract between poor (BALB/c) and high (C3H) drug responder mouse strains. Our data indicate that there is a genetic component explaining between-mouse variation in the efficacy of a standard dose of PLS in removing worms, and therefore warrant some caution in developing this therapy for wider scale use in the livestock industry, and even in human medicine.
- Published
- 2015
- Full Text
- View/download PDF